Results 21 to 30 of about 256,433 (249)

Real-world performance, long-term efficacy, and absence of bias in the artificial intelligence enhanced electrocardiogram to detect left ventricular systolic dysfunction

European Heart Journal - Digital Health, 2022
Aims Some artificial intelligence models applied in medical practice require ongoing retraining, introduce unintended racial bias, or have variable performance among different subgroups of patients.
D. Harmon, R. Carter, Michal Cohen-Shelly, A. Svatikova, Demilade A. Adedinsewo, P. Noseworthy, S. Kapa, F. Lopez‐Jimenez, P. Friedman, Z. Attia   +9 more
semanticscholar   +1 more source

Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction

Circulation, 2021
Supplemental Digital Content is available in the text. Background: Patients with left ventricular (LV) systolic dysfunction after myocardial infarction are at a high risk of developing heart failure.
K. Docherty, R. Campbell, K. Brooksbank, J. Dreisbach, P. Forsyth, R. Godeseth, T. Hopkins, A. Jackson, Matthew M. Y. Lee, A. McConnachie, G. Roditi, I. Squire, B. Stanley, P. Welsh, P. Jhund, M. Petrie, J. McMurray   +16 more
semanticscholar   +1 more source

Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes

Journal of Cardiothoracic Surgery, 2020
Background This study aims to evaluate the early and mid-term outcomes of mitral valve repair for degenerative mitral regurgitation (MR) in patients with left ventricular systolic dysfunction.
Jun Li, Yun Zhao, Tianyu Zhou, Yongshi Wang, Kai Zhu, Junyu Zhai, Yongxin Sun, Hao Lai, Chunsheng Wang   +8 more
doaj   +1 more source

Rethinking Revascularization in Left Ventricular Systolic Dysfunction [PDF]

Circulation: Heart Failure, 2017
Patients with chronic heart failure with reduced ejection fraction (HFrEF) now have multiple therapeutic options, including oral medications and cardiac devices, that improve quality of life, reduce the risk of readmission, and improve mortality. In the span of only decades, the goals of treatment have moved dramatically upstream from supportive care ...
Adam D, DeVore, Eric J, Velazquez
openaire   +2 more sources

Intracardiac Thrombus in Community-Acquired Klebsiella pneumonia – An Unprecedented Complication

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2022
Left ventricular thrombi commonly occur in the presence of left ventricular systolic dysfunction. Their occurrence in the presence of preserved left ventricular systolic function is extremely rare. Here we present a case of a diabetic lady with community
Ashish Kumar, Rohit Tandon, Bishav Mohan, Narender Pal Jain   +3 more
doaj   +1 more source

The extracellular matrix degradation markers as predictors of left ventricular systolic dysfunction among patients with STEMI

Сучасні медичні технології, 2021
The purpose of the study. To determine predictor value of the extracellular matrix degradation markers relative to the occurrence of left ventricular systolic dysfunction among patients with STEMI determined. Materials and methods.
I. M. Fushtey, E. V. Sid
doaj   +1 more source

Artificial Intelligence-Enabled ECG Algorithm to Identify Patients With Left Ventricular Systolic Dysfunction Presenting to the Emergency Department With Dyspnea

Circulation: Arrhythmia and Electrophysiology, 2020
Background: Identification of systolic heart failure among patients presenting to the emergency department (ED) with acute dyspnea is challenging. The reasons for dyspnea are often multifactorial.
Demilade A. Adedinsewo, R. Carter, Z. Attia, Patrick W. Johnson, A. Kashou, Jennifer Dugan, Michael L Albus, J. Sheele, F. Bellolio, P. Friedman, F. Lopez‐Jimenez, P. Noseworthy   +11 more
semanticscholar   +1 more source

Combination therapy using tafamidis and neurohormonal blockers for cardiac amyloidosis and a reduced ejection fraction: a case report

Journal of International Medical Research, 2022
Cardiac amyloidosis usually presents with diastolic dysfunction, but sometimes systolic dysfunction develops, particularly at its advanced stage. However, the therapeutic strategy for patients with cardiac amyloidosis and systolic dysfunction remains ...
Teruhiko Imamura, Toshihide Izumida, Masakazu Hori, Shuhei Tanaka, Koichiro Kinugawa   +4 more
doaj   +1 more source

Carvedilol improves left ventricular diastolic dysfunction in patients with transfusion-dependent thalassemia

Annals of Pediatric Cardiology, 2021
Background: Iron overload cardiomyopathy is the most common cause of death in patients with transfusion-dependent thalassemia. Aim: The aim of this study was to determine the efficacy of carvedilol treatment in patients with transfusion-dependent ...
Suchaya Silvilairat, Pimlak Charoenkwan, Suwit Saekho, Adisak Tantiworawit, Nipon Chattipakorn   +4 more
doaj   +1 more source

Successful Percutaneous Coronary Intervention for Chronic Total Occlusion in Left Ventricular Systolic Dysfunction Patients with and without Diabetes Mellitus. [PDF]

Rev Cardiovasc Med
Wu X, Li Q, Wu M, Huang H, Liu Z, Huang H, Wang L.   +6 more
europepmc   +3 more sources